litlas
ログインアカウント作成

Donald C. McMillan

1988–2025 年に発表

212
論文数
34,455
被引用数
101
h 指数
203
i10 指数

被引用数

Donald C. McMillan の年別被引用数1991 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 7 件1995 年: 被引用 2 件1996 年: 被引用 2 件1997 年: 被引用 8 件1998 年: 被引用 17 件1999 年: 被引用 23 件2000 年: 被引用 22 件2001 年: 被引用 38 件2002 年: 被引用 41 件2003 年: 被引用 46 件2004 年: 被引用 56 件2005 年: 被引用 82 件2006 年: 被引用 137 件2007 年: 被引用 140 件2008 年: 被引用 189 件2009 年: 被引用 187 件2010 年: 被引用 166 件2011 年: 被引用 196 件2012 年: 被引用 273 件2013 年: 被引用 312 件2014 年: 被引用 339 件2015 年: 被引用 382 件2016 年: 被引用 311 件2017 年: 被引用 299 件2018 年: 被引用 342 件2019 年: 被引用 1,206 件2020 年: 被引用 1,536 件2021 年: 被引用 1,394 件2022 年: 被引用 1,050 件2023 年: 被引用 650 件2024 年: 被引用 1,178 件2025 年: 被引用 414 件2026 年: 被引用 13 件

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 1,899 件、この内訳の 18.6%アメリカ合衆国: 引用元論文 1,476 件、この内訳の 14.4%イギリス: 引用元論文 894 件、この内訳の 8.8%日本: 引用元論文 708 件、この内訳の 6.9%イタリア: 引用元論文 551 件、この内訳の 5.4%ドイツ: 引用元論文 422 件、この内訳の 4.1%オランダ: 引用元論文 325 件、この内訳の 3.2%カナダ: 引用元論文 286 件、この内訳の 2.8%オーストラリア: 引用元論文 285 件、この内訳の 2.8%フランス: 引用元論文 240 件、この内訳の 2.3%韓国: 引用元論文 231 件、この内訳の 2.3%スペイン: 引用元論文 224 件、この内訳の 2.2%
0%18.6%その他 26.2%

機関

分野

  • Medicine80.6%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Immunology and Microbiology4%
  • Nursing2.3%
  • Neuroscience0.9%
  • Computer Science0.8%
  • その他2.3%

トピック

  • Inflammatory Biomarkers in Disease Prognosis12.1%
  • Nutrition and Health in Aging7.4%
  • Cancer Immunotherapy and Biomarkers4.5%
  • Colorectal Cancer Surgical Treatments2.8%
  • Immune cells in cancer2.4%
  • Frailty in Older Adults1.9%
  • その他68.9%

共著者

全論文

検索で開く
  1. Cancer-related inflammation and treatment effectiveness

    著者: Connie I. Diakos, Kellie A. Charles, Donald C. McMillan, Stephen Clarke - The Lancet Oncology 2014 被引用: 2,187

  2. ESPEN expert group recommendations for action against cancer-related malnutrition

    著者: Jann Arends, Vickie E. Baracos, Hartmut Bertz, Federico Bozzetti, Philip C. Calder, Nicolaas E.P. Deutz, Nicole Erickson, Alessandro Laviano, Michael P. Lisanti, Dileep N. Lobo, Donald C. McMillan, Maurizio Muscaritoli, Johann Ockenga, Matthias Pirlich, Florian Strasser, M.A.E. de van der Schueren, A. Van Gossum, Peter Vaupel, Arved Weimann - Clinical Nutrition 2017 被引用: 1,282

  3. The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

    著者: Graeme J.K. Guthrie, Kellie A. Charles, Campbell S.D. Roxburgh, Paul G. Horgan, Donald C. McMillan, Stephen Clarke - Critical Reviews in Oncology/Hematology 2013 被引用: 1,539

  4. The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer

    著者: Donald C. McMillan - Cancer Treatment Reviews 2012 被引用: 1,400

  5. Systemic inflammation, nutritional status and survival in patients with cancer

    著者: Donald C. McMillan - Current Opinion in Clinical Nutrition & Metabolic Care 2009 被引用: 1,009

  6. NF-κB pathways in the development and progression of colorectal cancer

    著者: Meera Patel, Paul G. Horgan, Donald C. McMillan, Joanne Edwards - Translational research 2018 被引用: 253

  7. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer

    著者: Yoshinaga Okugawa, Yuji Toiyama, Akira Yamamoto, Tsunehiko Shigemori, Shozo Ide, Takahito Kitajima, Hiroyuki Fujikawa, Hiromi Yasuda, Junichiro Hiro, Shigeyuki Yoshiyama, Takeshi Yokoe, Susumu Saigusa, Koji Tanaka, Yumiko Shirai, Minàko Kobayashi, Masaki Ohi, Toshimitsu Araki, Donald C. McMillan, Chikao Miki, Ajay Goel, Masato Kusunoki - Annals of Surgery 2019 被引用: 298

  8. Perioperative nutrition: Recommendations from the ESPEN expert group

    著者: Dileep N. Lobo, Luca Gianotti, Alfred Adiamah, Rocco Barazzoni, Nicolaas E.P. Deutz, Ketan Dhatariya, Paul L. Greenhaff, M. Hiesmayr, Dorthe Hjort Jakobsen, Stanisław Kłęk, Željko Krznarić, Olle Ljungqvist, Donald C. McMillan, Katie E. Rollins, Marina Panisic Sekeljic, Richard J.E. Skipworth, Zeno Stanga, Audrey Stockley, Ralph Stockley, Arved Weimann - Clinical Nutrition 2020 被引用: 288

  9. Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer

    著者: Campbell SD Roxburgh, Donald C. McMillan - Future Oncology 2009 被引用: 1,003

  10. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta -analysis

    著者: Ross D. Dolan, Stephen T. McSorley, Paul G. Horgan, Barry Laird, Donald C. McMillan - Critical Reviews in Oncology/Hematology 2017 被引用: 353

  11. Cancer cachexia: a nutritional or a systemic inflammatory syndrome?

    著者: Josh McGovern, Ross D. Dolan, Richard J.E. Skipworth, Barry Laird, Donald C. McMillan - British Journal of Cancer 2022 被引用: 128

  12. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

    著者: L M Forrest, Donald C. McMillan, C S McArdle, Wilson J. Angerson, David J. Dunlop - British Journal of Cancer 2003 被引用: 781

  13. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

    著者: Michael Proctor, David Morrison, Dinesh Talwar, Steven M. Balmer, D S O’Reilly, Alan K. Foulis, Paul G. Horgan, Donald C. McMillan - British Journal of Cancer 2011 被引用: 532

  14. Hypoalbuminemia Reflects Nutritional Risk, Body Composition and Systemic Inflammation and Is Independently Associated with Survival in Patients with Colorectal Cancer

    著者: Arwa S. Almasaudi, Ross D. Dolan, Christine A. Edwards, Donald C. McMillan - Cancers 2020 被引用: 160

  15. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis

    著者: Ross D. Dolan, Jason Eng Kiat Lim, Stephen T. McSorley, Paul G. Horgan, Donald C. McMillan - Scientific Reports 2017 被引用: 295

  16. Computed tomography‐defined low skeletal muscle index and density in cancer patients: observations from a systematic review

    著者: Josh McGovern, Ross D. Dolan, Paul G. Horgan, Barry Laird, Donald C. McMillan - Journal of Cachexia Sarcopenia and Muscle 2021 被引用: 112

  17. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series

    著者: James McDonald, Judith Sayers, Stefan D. Anker, Jann Arends, Trude R. Balstad, Vickie E. Baracos, Leo R. Brown, Asta Bye, Olav Dajani, Ross D. Dolan, Marie Fallon, Eilidh Fraser, Christine Griel, Aleksandra Grzyb, Marianne Jensen Hjermstad, Mariam Jamal‐Hanjani, Gunnhild Jakobsen, Stein Kaasa, Donald C. McMillan, Matthew Maddocks, Iain Philips, Inger Ottestad, Kieran F. Reid, Mariana S. Sousa, Melanie Rae Simpson, Ola Magne Vagnildhaug, Richard J.E. Skipworth, Tora S. Solheim, Barry Laird, the Cancer Cachexia Endpoints Working Group - Journal of Cachexia Sarcopenia and Muscle 2023 被引用: 49

  18. Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss

    著者: Donald C. McMillan, Walter S. Watson, Patricia O'Gorman, Tom Preston, Hazel R. Scott, Colin S. McArdle - Nutrition and Cancer 2001 被引用: 460

  19. Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: A systematic review

    著者: David G. Watt, Paul G. Horgan, Donald C. McMillan - Surgery 2015 被引用: 375

  20. The relationship between computed tomography‐derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer

    著者: Ross D. Dolan, Arwa S. Almasaudi, Ly B. Dieu, Paul G. Horgan, Stephen T. McSorley, Donald C. McMillan - Journal of Cachexia Sarcopenia and Muscle 2018 被引用: 177

  21. Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysis

    著者: Francesca Savioli, Elizabeth Morrow, Ross D. Dolan, László Romics, Alison Lannigan, Joanne Edwards, Donald C. McMillan - British journal of surgery 2022 被引用: 78

  22. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

    著者: Kathryn A.F. Pennel, Phimmada Hatthakarnkul, Colin S. Wood, Guang‐Yu Lian, Sara Samir Foad Al-Badran, Jean A. Quinn, Assya Legrini, Jitwadee Inthagard, Peter Alexander, Hester van Wyk, Ahmad Kurniawan, Umar Hashmi, Michael A. Gillespie, Megan L. Mills, Aula Ammar, Jennifer Hay, Ditte K. Andersen, Colin Nixon, Selma Rebus, David K. Chang, Caroline Kelly, Andrea Harkin, Janet Graham, David N. Church, Ian D. Tomlinson, Mark Saunders, Timothy Iveson, Tamsin R.M. Lannagan, René Jackstadt, Noori Maka, Paul G. Horgan, Campbell S.D. Roxburgh, Owen J. Sansom, Donald C. McMillan, Colin W. Steele, Nigel B. Jamieson, James H. Park, Antonia K. Roseweir, Joanne Edwards - Journal of Experimental & Clinical Cancer Research 2024 被引用: 45

  23. Cancer and systemic inflammation: treat the tumour and treat the host

    著者: Campbell S.D. Roxburgh, Donald C. McMillan - British Journal of Cancer 2014 被引用: 366

  24. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer

    著者: Michael Proctor, Donald C. McMillan, David Morrison, Colin D. Fletcher, Paul G. Horgan, Stephen Clarke - British Journal of Cancer 2012 被引用: 519